Smith, Salley & Associates reports 0.97% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Smith, Salley & Associates
Latest Disclosed Ownership	10,549 shares
Latest Disclosed Value	$ 639,822

On April 16, 2026 - Smith, Salley & Associates filed a 13F-HR form disclosing ownership of 10,549 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $552,979 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 10,652 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.97% during the quarter. The current value of the position is $500,339 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-16	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,549	-103	-0.97	640	11.32	0.0322
2026-01-27	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,652	1,486	16.21	575	38.98	0.0285
2025-10-20	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,166	-130	-1.40	413	-3.95	0.0213
2025-07-17	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,296	0	0.00	430	-24.03	0.0249
2025-04-25	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,296	0	0.00	567	7.81	0.0372
2025-01-15	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,296	-269	-2.81	526	6.28	0.0338
2024-10-24	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,565	-578	-5.70	495	17.34	0.0324
2024-07-29	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,143	-5,204	-33.91	421	-49.40	0.0302
2024-05-02	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,347	7,676	100.07	832	111.70	0.0646
2024-01-24	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,671	-5,795	-43.03	394	-49.68	0.0254
2023-10-27	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,466	917	7.31	782	-2.62	0.0580
2023-08-04	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,549	-150	-1.18	802	-8.86	0.0592
2023-05-03	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,699	626	5.19	880	1.38	0.0700
2023-02-03	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,073	670	5.88	869	7.03	0.0743
2022-11-01	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,403	118	1.05	811	-6.57	0.0755
2022-08-01	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,285	1,710	17.86	868	24.18	0.0751
2022-05-10	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,575	-1,384	-12.63	699	2.34	0.0514
2022-02-10	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,959	-2,550	-18.88	683	-14.52	0.0484
2021-11-05	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,509	1,725	14.64	799	1.40	0.0629
2021-08-09	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,784	884	8.11	788	14.53	0.0638
2021-04-30	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,900	1,876	20.79	688	23.08	0.0618
2021-01-28	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,024	43	0.48	559	3.33	0.0566
2020-11-05	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,981	6	0.07	541	2.46	0.0654
2020-08-04	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,975	-5,675	-38.74	528	-35.37	0.0705
2020-04-24	2020-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	14,650	-3,342	-18.57	817	-29.26	0.1359
2020-01-27	2019-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	17,992	13,981	348.57	1,155	468.97	0.1523
2019-10-30	2019-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	4,011	4,011		203		0.0288
2019-07-12	2019-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	0	-5,899	-100.00	0	-100.00
2019-05-03	2019-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	5,899	-18	-0.30	281	-8.77	0.0452
2019-02-05	2018-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	5,917	-57	-0.95	308	-16.98	0.0567
2018-11-06	2018-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	5,974	714	13.57	371	27.49	0.0585
2018-08-10	2018-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	5,260	-3,197	-37.80	291	-45.61	0.0498
2018-05-09	2018-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	8,457	167	2.01	535	5.31	0.0959
2018-02-12	2017-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	8,290	133	1.63	508	-2.31	0.0910
2017-11-02	2017-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	8,157	3,382	70.83	520	95.49	0.0996
2017-07-25	2017-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	4,775	-321	-6.30	266	-3.97	0.0535
2017-05-05	2017-03-31	13F	Bristol Myers Squibb	COM	110122108	5,096	-54,854	-91.50	277	-92.09	0.0568
2017-02-01	2016-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	59,950	-121	-0.20	3,504	8.18	0.7296
2016-11-14	2016-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	60,071	10,323	20.75	3,239	-11.48	0.7182
2016-07-29	2016-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	49,748	8,085	19.41	3,659	37.50	0.8526
2016-05-10	2016-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	41,663	485	1.18	2,661	-6.07	0.6669
2016-02-10	2015-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	41,178	-143	-0.35	2,833	15.82	0.7062
2015-11-12	2015-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	41,321	1,323	3.31	2,446	-8.11	0.6600
2015-08-11	2015-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	39,998	-5,722	-12.52	2,662	-9.73	0.6777
2015-05-05	2015-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	45,720	45,720	0.00	2,949		0.7515
2015-02-04	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	0	-43,445	-100.00	0	-100.00
2014-11-12	2014-09-30	13F	Bristol-Myers Squibb	COM	110122108	43,445	14,233	48.72	2,223	56.88	0.5899
2014-08-13	2014-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	29,212	15,882	119.14	1,417	104.47	0.3784
2014-05-12	2014-03-31	13F	Bristol Myers Squibb	COM	110122108	13,330	3,045	29.61	693	26.69	0.4331
2014-02-11	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	10,285	4,084	65.86	547	90.59	0.3569
2013-11-12	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	6,201	1,235	24.87	287	29.28	0.2312
2013-08-13	2013-06-30	13F	Bristol Myers Squibb	COM	110122108	4,966	4,966		222		0.1786

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.